195 related articles for article (PubMed ID: 16399231)
1. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats.
Wei M; Hori TA; Ichihara T; Wanibuchi H; Morimura K; Kang JS; Puatanachokchai R; Fukushima S
Cancer Lett; 2006 Jan; 231(2):304-8. PubMed ID: 16399231
[TBL] [Abstract][Full Text] [Related]
2. Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol.
Wanibuchi H; Wei M; Karim MR; Morimura K; Doi K; Kinoshita A; Fukushima S
Toxicol Pathol; 2006; 34(3):232-6. PubMed ID: 16698719
[TBL] [Abstract][Full Text] [Related]
3. Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats.
Murai T; Mori S; Kang JS; Morimura K; Wanibuchi H; Totsuka Y; Fukushima S
Toxicol Pathol; 2008 Apr; 36(3):472-7. PubMed ID: 18413788
[TBL] [Abstract][Full Text] [Related]
4. Lack of potential of low dose N-nitrosodimethylamine to induce preneoplastic lesions, glutathione S-transferase placental form-positive foci, in rat liver.
Fukushima S; Wanibuchi H; Morimura K; Nakae D; Tsuda H; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
Cancer Lett; 2005 May; 222(1):11-5. PubMed ID: 15837536
[TBL] [Abstract][Full Text] [Related]
5. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Takasuka N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
Cancer Lett; 2003 Feb; 191(1):35-40. PubMed ID: 12609707
[TBL] [Abstract][Full Text] [Related]
6. No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen.
Hoshi M; Morimura K; Wanibuchi H; Wei M; Okochi E; Ushijima T; Takaoka K; Fukushima S
Toxicol Sci; 2004 Oct; 81(2):273-9. PubMed ID: 15282409
[TBL] [Abstract][Full Text] [Related]
7. Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3,8-dimethylimidazo [4,5-f ]quinoxaline (MeIQx) in rats.
Ichihara T; Wanibuchi H; Totsuka Y; Morimura K; Wei M; Nakae D; Fukushima S
Cancer Sci; 2004 Dec; 95(12):943-8. PubMed ID: 15596042
[TBL] [Abstract][Full Text] [Related]
8. Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes.
Puatanachokchai R; Morimura K; Wanibuchi H; Oka M; Kinoshita A; Mitsuru F; Yamaguchi S; Funae Y; Fukushima S
Cancer Lett; 2006 Aug; 240(1):102-13. PubMed ID: 16246485
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol: evidence for a threshold.
Kushida M; Wanibuchi H; Morimura K; Kinoshita A; Kang JS; Puatanachokchai R; Wei M; Funae Y; Fukushima S
Cancer Sci; 2005 Nov; 96(11):747-57. PubMed ID: 16271068
[TBL] [Abstract][Full Text] [Related]
10. Post-initiation inhibition of MeIQx hepatocarcinogenesis in rats by cysteine.
Ogawa M; Wanibuchi H; Nishkawa T; Yano Y; Otani S; Totsuka Y; Wakabayashi K; Nakae D; Fukushima S
Osaka City Med J; 2003 Jun; 49(1):21-30. PubMed ID: 14703096
[TBL] [Abstract][Full Text] [Related]
11. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
[TBL] [Abstract][Full Text] [Related]
12. Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: relevance to risk assessment.
Fukushima S
Cancer Lett; 1999 Sep; 143(2):157-9. PubMed ID: 10503896
[TBL] [Abstract][Full Text] [Related]
13. Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine.
Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Uehara N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F; Wakabayashi K; Totsuka Y
Jpn J Cancer Res; 2002 Oct; 93(10):1076-82. PubMed ID: 12417036
[TBL] [Abstract][Full Text] [Related]
14. Modifying effects of propolis on MeIQx promotion of rat hepatocarcinogenesis and in a female rat two-stage carcinogenesis model after multiple carcinogen initiation.
Kawabe M; Lin C; Kimoto N; Sano M; Hirose M; Shirai T
Nutr Cancer; 2000; 37(2):179-86. PubMed ID: 11142091
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens.
Shimizu T; Fan Y; Yamana D; Miura T; Nanashima N; Yamada T; Tsuchida S
Cancer Sci; 2010 May; 101(5):1093-8. PubMed ID: 20180811
[TBL] [Abstract][Full Text] [Related]
16. [Effects of 16-week dietary administration of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in rats].
Kasahara K; Furukawa F; Nishikawa A; Tanakamaru Z; Kim HC; Ikezaki S; Takahashi M
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):107-11. PubMed ID: 9641823
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
[TBL] [Abstract][Full Text] [Related]
18. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
Waddell WJ; Fukushima S; Williams GM
Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
[TBL] [Abstract][Full Text] [Related]
19. Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work.
Tsuda H; Fukushima S; Wanibuchi H; Morimura K; Nakae D; Imaida K; Tatematsu M; Hirose M; Wakabayashi K; Moore MA
Toxicol Pathol; 2003; 31(1):80-6. PubMed ID: 12597451
[TBL] [Abstract][Full Text] [Related]
20. Suppression of glutathione S-transferase placental form-positive foci development in rat hepatocarcinogenesis by Chlorella pyrenoidosa.
Takekoshi H; Mizoguchi T; Komasa Y; Chubachi H; Inoue Y; Imanishi H; Nakano M
Oncol Rep; 2005 Aug; 14(2):409-14. PubMed ID: 16012723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
